Merck & Co., Inc. Extends Deadline For Talks On Dutch Organon Closures

December 17, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

AMSTERDAM Dec 17 (Reuters) - U.S. drugmaker Merck & Co Inc (MRK.N) said on Friday it has further postponed the closure of some of its Dutch operations pending discussions about possible alternatives, including a sale of the R&D site.

Twitter
LinkedIn
Facebook
Email
Print

Real estate Europe

Merck & Co.